Systematic Review and Critical Appraisal of Prediction Models for Readmission in Coronary Artery Disease Patients: Assessing Current Efficacy and Future Directions
Yunhao Zhang,Xuejiao Zhu,Fuer Gao,Shulan Yang
DOI: https://doi.org/10.2147/rmhp.s451436
2024-03-12
Risk Management and Healthcare Policy
Abstract:Yunhao Zhang, 1 Xuejiao Zhu, 1 Fuer Gao, 1 Shulan Yang 2 1 College of Nursing, Hangzhou Normal University, Hangzhou, People's Republic of China; 2 Department of Nursing, Zhejiang Hospital, Hangzhou, People's Republic of China Correspondence: Xuejiao Zhu, College of Nursing, Hangzhou Normal University, Hangzhou, 311121, People's Republic of China, Email Purpose: Coronary artery disease (CAD) patients frequently face readmissions due to suboptimal disease management. Prediction models are pivotal for detecting early unplanned readmissions. This review offers a unified assessment, aiming to lay the groundwork for enhancing prediction models and informing prevention strategies. Methods: A search through five databases (PubMed, Web of Science, EBSCOhost, Embase, China National Knowledge Infrastructure) up to September 2023 identified studies on prediction models for coronary artery disease patient readmissions for this review. Two independent reviewers used the CHARMS checklist for data extraction and the PROBAST tool for bias assessment. Results: From 12,457 records, 15 studies were selected, contributing 30 models targeting various CAD patient groups (AMI, CABG, ACS) from primarily China, the USA, and Canada. Models utilized varied methods such as logistic regression and machine learning, with performance predominantly measured by the c-index. Key predictors included age, gender, and hospital stay duration. Readmission rates in the studies varied from 4.8% to 45.1%. Despite high bias risk across models, several showed notable accuracy and calibration. Conclusion: The study highlights the need for thorough external validation and the use of the PROBAST tool to reduce bias in models predicting readmission for CAD patients. Keywords: coronary artery disease, readmission, prediction model, systematic review Coronary Artery Disease (CAD), characterized by the accumulation of cholesterol and other substances in the coronary arteries leading to arterial narrowing or blockage, 1 exerts considerable pressure on healthcare systems worldwide. 2 CAD patients often require repeated readmissions due to inadequate disease control. 3,4 In China, the 30-day unplanned readmission rate for CAD patients stands at 6.3%, 5 closely paralleling the 7.5% reported in the United States National Database. 6 Readmissions, defined as hospitalizations within a specific timeframe following discharge, vary in nature. "All-cause readmission" includes any readmission regardless of cause, 7 while "unplanned readmission" pertains to those unforeseen at the time of discharge. 8 The latter is often linked to increased mortality and healthcare costs. 9–11 Meanwhile, CAD patients face potential readmissions for multiple reasons, including recurrent myocardial infarction, unstable angina, and heart failure, necessitating a focus on all readmission types due to the chronicity and management complexity of CAD. Hence, precise and early assessment of unplanned readmission risk in CAD patients, coupled with targeted preventive measures against risk factors, is of utmost importance. 12 Prediction models are instrumental in identifying such risks by analyzing relevant factors to estimate rehospitalization probabilities. A foundational study by Engoren et al 13 in 2013, employing genetic programming, logistic regression, and artificial neural networks, marked a pivotal advancement in predicting post-surgical readmissions for CAD patients. Subsequent models have varied in participants, predictors, and outcomes, facilitating personalized risk assessments. 14 However, their clinical adoption is impeded by insufficient evidence on model performance and utility. Currently, there is an absence of comprehensive systematic reviews assessing these models' methodological quality, predictive accuracy, and clinical applicability. This systematic review seeks to uncover and detail research focused on the development and/or validation of prediction models for readmission among CAD patients, while also rigorously assessing the potential bias and clinical applicability of these models. This systematic review was conducted following the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). 15 A protocol for this study was registered with PROSPERO (CRD42023429102). A systematic literature search was conducted in PubMed, Embase, Web of Science, EBSCOhost, and CNKI (China National Knowledge Infrastructure), targeting publications in Chinese and English, with the search timeframe spanning from the inception of each database/website until September 30, 2023. The electronic sear -Abstract Truncated-
health care sciences & services,health policy & services